Medical News

RSS

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

Human Longevity announces acquisition of Cypher Genomics

Human Longevity, Inc., the genomics-based, technology-driven company, announced today that the company has acquired Cypher Genomics, Inc., a leading genome informatics company offering highly accurate, rapid and robust human genomic interpretation software solutions.

30 Nov 2015

Medical professionals compare different treatment methods for Neuromyelitis optica

In the course of a study conducted throughout Germany, medical professionals have compared different treatment methods for Neuromyelitis optica, an inflammatory disease of the central nervous system. It turned out that the best results were not achieved with conventional steroid therapy. Under the auspices of the Ruhr-Universität Bochum and the Hannover Medical School, the team published their findings in the journal Annals of Neurology.

30 Nov 2015

Scientists discover genetic causes of Goldenhar syndrome

Some children are born with cleft palates and, of those children, some have an asymmetrical face and a malformed ear. A team of scientists led by Berlin-based researcher Enno Klußmann of the Max Delbrück Center for Molecular Medicine has taken an important step towards discovering the genetic causes of this condition, known as Goldenhar syndrome.

30 Nov 2015

UVA opens clinical trial to examine non-surgical treatment for lower urinary tract symptoms

University of Virginia Health System researchers have opened a national clinical trial examining a non-surgical treatment for lower urinary tract symptoms caused by an enlarged prostate.

30 Nov 2015

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

In addition to their well established cholesterol lowering benefits, statins also have potent anti-inflammatory, anti-fibrotic and antioxidant effects, which continue to be identified in a wide range of diseases.

30 Nov 2015

Premera Blue Cross, Express Scripts renew pharmacy benefit agreement

Premera Blue Cross and Express Scripts today announced an early renewal of the companies' long-standing pharmacy benefit agreement. The partnership, which began in 1999, will now extend through at least 2019.

30 Nov 2015

Olympus introduces EZDilate balloon dilator for improved control in endoscopic balloon dilation procedures

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today its new 510(k) cleared EZDilate multi-stage endoscopic balloon dilator for improved precision and control in endoscopic balloon dilation procedures.

30 Nov 2015

SuperCom awarded $8 million in new contracts

SuperCom Ltd., a leading provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, today announced that it has been awarded new contracts, totaling approximately $8 million. The Company expects to deliver and recognize the full value of the orders during the first half of 2016.

30 Nov 2015

Precision Image Analysis expands capabilities as provider of medical imaging services

Precision Image Analysis Inc., a leading provider of Post-Processing services, is pleased to announce a dramatic expansion of its capabilities as a provider of medical imaging services. Building on its ISO-9001:2008 certification for its Quality Management System, PIA has adopted and implemented comprehensive Core Lab protocols and procedures.

30 Nov 2015

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Elbit Imaging Ltd. announced today that it was informed by InSightec Ltd., that the Korean Ministry of Food and Drug Safety has approved its Exablate Neuro system to treat movement, pain and behavioral disorders.

30 Nov 2015

Researchers discover drug target and genetic pathway for graft-versus-host disease

A Seattle Children's Research Institute lab has discovered a genetic pathway that can be targeted with existing drugs to prevent graft-versus-host disease (GVHD), a common and deadly complication of bone marrow transplants.

30 Nov 2015

Mexico Healthcare and Life Sciences Report 2015 released by Pharmaboardroom

Pharmaboardroom releases its new 98-page Mexico Healthcare and Life Sciences Report 2015. It offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the second largest pharma and healthcare market in Latin America, a country of over 122 million people.

30 Nov 2015

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, announces that it has entered into a strategic drug discovery collaboration with Pfizer Inc. to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas.

30 Nov 2015

BRCA1 depletion can potentially contribute to cognitive deficits in Alzheimer's disease

Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer's disease.

30 Nov 2015

Study analyzes effect of music therapy on palliative care patients

Music therapy can enhance terminally ill patients' wellbeing and relaxation. This treatment has been known since the 1970s, but there is little scientific research on the subject. A recent randomized controlled trial by Marco Warth et al. in Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 788-94) analyzes the effect of music therapy on palliative care patients.

30 Nov 2015

Medical News

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Human Longevity announces acquisition of Cypher Genomics

Medical professionals compare different treatment methods for Neuromyelitis optica

Scientists discover genetic causes of Goldenhar syndrome

UVA opens clinical trial to examine non-surgical treatment for lower urinary tract symptoms

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

Premera Blue Cross, Express Scripts renew pharmacy benefit agreement

Olympus introduces EZDilate balloon dilator for improved control in endoscopic balloon dilation procedures

SuperCom awarded $8 million in new contracts

Precision Image Analysis expands capabilities as provider of medical imaging services

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Researchers discover drug target and genetic pathway for graft-versus-host disease

Mexico Healthcare and Life Sciences Report 2015 released by Pharmaboardroom

Heptares announces strategic drug discovery collaboration with Pfizer

BRCA1 depletion can potentially contribute to cognitive deficits in Alzheimer's disease

Study analyzes effect of music therapy on palliative care patients

Norwegian model created for measuring gender equality becomes international success

New research reveals how gaps between gene interactions influence disease risk

Unplugged Powered Suit supports human movement

Establishing supervised injection facilities in Toronto and Ottawa would be cost-effective, say researchers

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News